Kerr W. Holbrook - 06 Mar 2025 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP, Chief Commercial Officer
Signature
/s/ Mojirade James, as attorney-in-fact for Kerr W. Holbrook
Issuer symbol
AVNS
Transactions as of
06 Mar 2025
Net transactions value
-$199,557
Form type
4
Filing time
10 Mar 2025, 11:50:17 UTC
Previous filing
06 Mar 2025
Next filing
11 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Sale $106,778 -7,000 -7.9% $15.25 82,047 06 Mar 2025 Direct
transaction AVNS Common Stock Tax liability $37,852 -2,474 -3% $15.30 79,573 06 Mar 2025 Direct F1
transaction AVNS Common Stock Tax liability $54,927 -3,590 -4.5% $15.30 75,983 06 Mar 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 7,997 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2025. Each TRSU is the economic equivalent of one share of Common Stock.
F2 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 12,069 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2024 and (ii) vested on March 6, 2025. Each TRSU is the economic equivalent of one share of Common Stock.